CellSource Co., Ltd.

Tokyo Stock Exchange 4880.T

CellSource Co., Ltd. Free Cash Flow Per Share for the year ending October 31, 2024: USD 0.02

CellSource Co., Ltd. Free Cash Flow Per Share is USD 0.02 for the year ending October 31, 2024, a -89.85% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

CellSource Co., Ltd. Free Cash Flow Per Share for the year ending October 31, 2023 was USD 0.17, a -36.85% change year over year.
CellSource Co., Ltd. Free Cash Flow Per Share for the year ending October 31, 2022 was USD 0.27, a -31.96% change year over year.
CellSource Co., Ltd. Free Cash Flow Per Share for the year ending October 31, 2021 was USD 0.40, a 151.58% change year over year.
CellSource Co., Ltd. Free Cash Flow Per Share for the year ending October 31, 2020 was USD 0.16, a 107.10% change year over year.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

Tokyo Stock Exchange: 4880.T

CellSource Co., Ltd.

CEO	Mr. Takashi Sawada
IPO Date	Oct. 29, 2019
Location	Japan
Headquarters	Shibuya Mitake Building
Employees	151
Sector	Healthcare
Industries Biotechnology Composite Materials Consumer Packaged Goods Cosmetics Eyewear Personal Care Pharmaceuticals Plastics

Description

CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years